Skip to content

Moat Ross Insider Trading -- Recent SEC Form 4 Transactions

Moat Ross (CIK 1857177) reported 41 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-11-03). Recent activity: Buy KNSA (10,895 shares), Buy KNSA (21,059 shares), Buy KNSA (3,760 shares), Buy KNSA (1,658 shares), Buy KNSA (16,112 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERBuy10,895$196,764
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERBuy21,059$233,755
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERBuy3,760$45,007
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERBuy1,658$21,504
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERBuy16,112$286,149
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERBuy16,111$173,354
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERSell37,775$3.5M
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERSell722$67,904
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERSell8,430$792,167
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERSell6,282$596,287
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERSell3,672$352,622
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERSell1,760$170,896
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERSell2,575$251,732
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERBuy9,412$169,981
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERBuy12,302$267,815
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERBuy6,263$143,360
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERSell6,681$609,508
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERSell8,932$822,191
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERSell11,642$1.1M
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERSell15,114$1.4M
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERBuy2,477$0
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERBuy1,611$0
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERBuy1,740$0
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERBuy2,457$0
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF OPERATING OFFICERSell4,007$317,675

Source: SEC Form 4 filings · as of 2026-11-03